Realcan Pharmaceutical Group Co., Ltd.
002589.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.46B
Close$
$-1.52
151.3% downside
Current Fair Value
151.3% downsideOvervalued by 151.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.46 Billion |
|---|---|
| Enterprise Value | $7.02 Billion |
| Dividend Yield | $0.00 (0.06%) |
| Earnings per Share | $0.01 |
| Beta | 0.28 |
| Outstanding Shares | 1,470,071,812 |
Return
| Return on Equity | 0.17% |
|---|---|
| Return on Assets | 0.06% |
| Return on Invested Capital | 1.92% |
Valuation & Multiples
| P/E Ratio | 549.18 |
|---|---|
| PEG | -678.83 |
| Price to Sales | 0.74 |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | 0.98 |
| Enterprise Value to EBIT | 64.08 |
| Enterprise Value to Net Income | 776 |
| Total Debt to Enterprise | 1.18 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Realcan Pharmaceutical Group Co., Ltd.
2,407 employees
CEO: Xu Han Realcan Pharmaceutical Group Co., Ltd. operates as a global supplier, distributing pharmaceuticals, vaccines, medical devices, and consumable medical products to healthcare institutions across the world. Beyond its core distribution acti...